Table 3.
Logistic regression of variables associated with either microvascular or macrovascular complications in a cohort of 471 people with type 1 diabetes
| OR (95% CI)* | |
|---|---|
| Microvascular complications | |
| Duration of diabetes (years) | 1.12 (1.08–1.15) |
| Cumulative average of A1C (%) | 1.20 (1.01–1.41) |
| Cardiovascular disease | |
| No | 1.00 |
| Yes | 4.69 (1.01–21.84) |
| Hypertension (mmHg) | |
| No | 1.00 |
| Yes | 1.51 (0.95–2.40) |
| Fasting C-peptide (nmol/l) | |
| <0.06 | 1.00 |
| ≥0.06 | 0.59 (0.37–0.94) |
| Macrovascular complications | |
| Duration of diabetes (years) | 1.05 (0.99–1.11) |
| Hypertension (mmHg) | |
| No | 1.00 |
| Yes | 3.90 (1.40–10.89) |
| Microvascular complications | |
| No | 1.00 |
| Yes | 9.66 (1.18–78.86) |
| LDL cholesterol (mmol/l) | 1.90 (1.12–3.22) |
| Mean A1C (%) | 0.93 (0.57–1.50) |
| C-peptide (nmol/l) | |
| <0.06 | 1.00 |
| ≥0.06 | 0.77 (0.38–1.58) |
Adjusted for age, sex, and all other variables in the model.